Expression and clinical significance of VISTA, B7-H3, and PD-L1 in gliomaLi-Chong Wang, Liangxue Zhou, Hong-Chi Yu et al.|Clinical Immunology|2022Cited by 28
Case Report: Successful Use of BRAF/MEK Inhibitors in Aggressive BRAF-mutant CraniopharyngiomaZe-Pei Wu, Jianguo Xu, Yuelong Wang et al.|World Neurosurgery|2023Cited by 13